Discovering new CDK2 inhibitors by molecular docking and drug-likeness-based virtual screening for potential anticancer uses.
Worldwide, cancer ranks as the second most lethal disease. There are several potential anticancer therapeutic targets, but CDK2 stands out. Not many third-generation CDK2 inhibitors targeting the kinase domain have made it to market yet, but there are plenty of first- and second-generation inhibitor...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Árabe |
| Baskı/Yayın Bilgisi: |
Egyptian Russian University
2024-10-01
|
| Seri Bilgileri: | ERU Research Journal |
| Konular: | |
| Online Erişim: | https://erurj.journals.ekb.eg/article_351728_db17859d93dee0c5684bb90496169c46.pdf |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|
